Page last updated: 2024-10-21

edelfosine and Cancer of Prostate

edelfosine has been researched along with Cancer of Prostate in 1 studies

edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.

Research Excerpts

ExcerptRelevanceReference
"Edelfosine is a synthetic alkyl-lysophospholipid that possesses significant antitumor activity in several human tumor models."1.43Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity. ( Burnstein, KL; Mu, Z; Philip, S; Pollack, A; Shareef, MM; Stoyanova, R; Udayakumar, TS, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Udayakumar, TS1
Stoyanova, R1
Shareef, MM1
Mu, Z1
Philip, S1
Burnstein, KL1
Pollack, A1

Other Studies

1 other study available for edelfosine and Cancer of Prostate

ArticleYear
Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:6

    Topics: Activating Transcription Factor 3; Androgen Antagonists; Animals; Apoptosis; Cell Line, Tumor; Cell

2016